Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UC Berkeley study indicates promise of Chinese herbal medicine in treatment of chronic hepatitis B

02.10.2002


Chinese herbal medicine combined with standard therapy may be more effective than standard therapy alone for treatment of chronic hepatitis B, according to an analysis of randomized, controlled trials led by University of California, Berkeley, researchers.



Researchers analyzed 27 clinical trials in which chronic hepatitis B patients using Chinese herbal medicine alone, or with interferon alfa, were compared with a control group of patients that were taking only interferon alfa. The protein interferon alfa is a standard treatment for hepatitis B infection. Some of its side effects include strong flu-like symptoms, fatigue and depression.

The meta-analysis, to be published Oct. 1 in the American Journal of Public Health, found that the most encouraging results came from patients who used a combination of Chinese herbal treatments and interferon alfa.


"The results are encouraging enough that, if I had chronic hepatitis B and had previously failed interferon alfa treatment, I would talk to my doctor about combining interferon alfa with Chinese herbal medicine," said Michael McCulloch, a doctoral student in epidemiology at UC Berkeley’s School of Public Health and lead author of the study.

According to the World Health Organization, 2 billion people worldwide are infected with hepatitis B, 350 million of whom have the chronic form of the disease. About three-fourths of those with chronic hepatitis B live in Asia.

"There is a wealth of data about hepatitis B from researchers in Asia because the disease is endemic in that part of the world, but accessing that information has been - and still is - difficult because few of those studies are published in English-language journals," said McCulloch, who is also a research fellow at the Chinese Academy of Sciences in Beijing.

McCulloch, who earned his bachelor’s degree in Chinese studies at UC Berkeley, searched through six databases of medical literature, including clinical trials data published in Chinese-language journals.

The ingredients in the herbal treatments included mixtures of plant and root extracts, and they varied from study to study. Two of the 27 studies specifically looked at bufotoxin, an extract from the skin of the toad Bufo gargarizans. Another two studied kurorinone, an extract from the root of the plant Sophorae flavescentis.

The authors only included trials in which patients used Chinese herbal medicine alone or with interferon alfa and were then compared with a control group using only interferon alfa at least three times per week. The studies were required to include data on at least one of three markers of infection: levels of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg) and hepatitis B virus (HBV) DNA. All three measures indicate an active infection.

Overall, Chinese herbal medicine combined with interferon alfa was 1.5 to 2 times as effective as interferon alfa alone in reducing the hepatitis B viral load to undetectable levels for all three measures of infection. In particular, bufotoxin combined with interferon alfa was significantly more effective than interferon alfa alone in measures of HBeAg and HBV DNA, but not for measures of the surface antigen. Kurorinone was nearly as effective as interferon alfa in the two studies that tested it.

For measures of the surface antigen, patients receiving herbal treatment alone performed twice as well as those receiving only interferon alfa. The results did not differ significantly between the two groups for measures of HBeAg or HBV DNA.

"Bufotoxin and kurorinone have been singled out as having the best potential for being investigated for drugs," said McCulloch, a licensed acupuncturist for 16 years. "However, it may be that the key to the way these herbal therapies work is by acting together as a group. That’s one of the great challenges in studying herbal treatments, yet it is one of the most fascinating aspects of Chinese medicines. These particular mixtures are a distillation of centuries of clinical use."

The investigators also showed that the quality of the studies left much room for improvement. Many of the studies had incomplete information on how patients were randomized, and "blinding" of patients and doctors to the type of treatment administered did not occur in most of the studies.

"We cannot make firm conclusions about the use of Chinese herbal medicines based upon the results from these clinical trials," said Dr. Jack Colford, associate professor of epidemiology at UC Berkeley’s School of Public Health and senior researcher for the study. "But the findings revealed by this analysis certainly justify additional investigation of these herbal therapies in more rigorous trials."


Other co-authors of the study are Michael Broffman, co-founder with McCulloch of the Pine Street Clinic in San Anselmo; and Dr. Jin Gao, senior researcher and director of the Institute of Biophysics at the Chinese Academy of Sciences

Sarah Yang | EurekAlert!
Further information:
http://www.berkeley.edu/

More articles from Health and Medicine:

nachricht Custom-tailored strategy against glioblastomas
26.09.2016 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New leukemia treatment offers hope
23.09.2016 | King Abdullah University of Science and Technology

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New welding process joins dissimilar sheets better

Friction stir welding is a still-young and thus often unfamiliar pressure welding process for joining flat components and semi-finished components made of light metals.
Scientists at the University of Stuttgart have now developed two new process variants that will considerably expand the areas of application for friction stir welding.
Technologie-Lizenz-Büro (TLB) GmbH supports the University of Stuttgart in patenting and marketing its innovations.

Friction stir welding is a still-young and thus often unfamiliar pressure welding process for joining flat components and semi-finished components made of...

Im Focus: First quantum photonic circuit with electrically driven light source

Optical quantum computers can revolutionize computer technology. A team of researchers led by scientists from Münster University and KIT now succeeded in putting a quantum optical experimental set-up onto a chip. In doing so, they have met one of the requirements for making it possible to use photonic circuits for optical quantum computers.

Optical quantum computers are what people are pinning their hopes on for tomorrow’s computer technology – whether for tap-proof data encryption, ultrafast...

Im Focus: OLED microdisplays in data glasses for improved human-machine interaction

The Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP has been developing various applications for OLED microdisplays based on organic semiconductors. By integrating the capabilities of an image sensor directly into the microdisplay, eye movements can be recorded by the smart glasses and utilized for guidance and control functions, as one example. The new design will be debuted at Augmented World Expo Europe (AWE) in Berlin at Booth B25, October 18th – 19th.

“Augmented-reality” and “wearables” have become terms we encounter almost daily. Both can make daily life a little simpler and provide valuable assistance for...

Im Focus: Artificial Intelligence Helps in the Discovery of New Materials

With the help of artificial intelligence, chemists from the University of Basel in Switzerland have computed the characteristics of about two million crystals made up of four chemical elements. The researchers were able to identify 90 previously unknown thermodynamically stable crystals that can be regarded as new materials. They report on their findings in the scientific journal Physical Review Letters.

Elpasolite is a glassy, transparent, shiny and soft mineral with a cubic crystal structure. First discovered in El Paso County (Colorado, USA), it can also be...

Im Focus: Complex hardmetal tools out of the 3D printer

For the first time, Fraunhofer IKTS shows additively manufactured hardmetal tools at WorldPM 2016 in Hamburg. Mechanical, chemical as well as a high heat resistance and extreme hardness are required from tools that are used in mechanical and automotive engineering or in plastics and building materials industry. Researchers at the Fraunhofer Institute for Ceramic Technologies and Systems IKTS in Dresden managed the production of complex hardmetal tools via 3D printing in a quality that are in no way inferior to conventionally produced high-performance tools.

Fraunhofer IKTS counts decades of proven expertise in the development of hardmetals. To date, reliable cutting, drilling, pressing and stamping tools made of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

European Health Forum Gastein 2016 kicks off today

28.09.2016 | Event News

Laser use for neurosurgery and biofabrication - LaserForum 2016 focuses on medical technology

27.09.2016 | Event News

Experts from industry and academia discuss the future mobile telecommunications standard 5G

23.09.2016 | Event News

 
Latest News

New imaging technique in Alzheimer’s disease - opens up possibilities for new drug development

28.09.2016 | Medical Engineering

Innovate coating extends the life of materials for industrial use

28.09.2016 | Materials Sciences

Blockchain Set to Transform the Financial Services Market

28.09.2016 | Business and Finance

VideoLinks
B2B-VideoLinks
More VideoLinks >>>